Download presentation
Presentation is loading. Please wait.
Published byGrace Rodgers Modified over 8 years ago
1
Cancer Companies
2
Companies? Ultimate goal: CURE CANCER Pharmaceutical Biotechnology Research Centers A lot of them have “bio” “pharm” “tech” in their names!
3
Pharmaceutical Development of therapeutics Cancer treatment methods Often times – research based Constant battle with FDA Big names: Genetech, Pfizer, Johnson and Johnson
4
Biotechnology Molecular assay development for detection of cancerous cells Cancer screening process development Manufacturing reagents Aid the research process
5
Cells? Where do they come from? ATCC most of the time Is using a cell line actually an accurate way to perform research in lab setting?
6
Problems? Battle with FDA Safety High cost It won’t go down any time soon The new drug for prostate cancer (Medivation) costs $7,450/month! It’s actually going up!! Provenge costs $93,000 for a course of treatment and extends life by an average of four months. Yervoy costs $120,000 for three-and-a-half months. (Economist) Competition So many companies! Over 100 in JUST North Carolina They need to co-exist in order to maximize benefits though
7
Future? Battle with FDA will never go away Public/patients want the ‘cure for cancer’ Big dreams success?
8
Discussion points What are your thoughts on government regulation of therapeutic drugs? Is government regulation impeding the advancement of cure for cancer? Do pros outweigh the cons?
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.